跳至主要内容
临床试验/NCT07646977
NCT07646977招募中不适用

CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年7月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2

研究概览

简要总结

The aim of this study is to evaluate the effects of coronary thrombus modification on preventing the microvascular damage associated with primary percutaneous coronary intervention (PCI), and to limit the associated myocardial damage assessed by myocardial salvage index after 3 months. Furthermore, the project will evaluate coronary microvascular damage assessed invasively using both continuous and bolus thermodilution before and after stent implantation. In addition, the project will evaluate the diagnostic ability and associations of pre-stenting invasive physiological measurement to cardiac magnetic resonance imaging measurements.

详细描述

Background: ST-elevation segment myocardial infarction (STEMI) most often occurs when an atherosclerotic plaque ruptures, causing blockage of the epicardial coronary artery leading to transmural ischemia of the myocardium. Due to ongoing ischemia, rapid restoration of blood flow with primary percutaneous coronary intervention (PCI) is vital to prevent further damage to the myocardium.

However, reopening of the coronary artery is by itself associated with damage to the myocardium, known as reperfusion injury. Reperfusion injury is a complex phenomenon mediated by several factors caused by the rapid restoration of blood flow. Oxidative stress, accumulation of intracellular calcium, rapid restoration of pH, and induction of inflammation are some of the underlying biological mechanisms.

Furthermore, the primary PCI procedure can cause distal embolization of the thrombus causing microvascular damage. In STEMI, coronary microcirculation plays a crucial role in myocardial reperfusion and recovery and cannot be visualizable by coronary angiography (CAG). The coronary microvascular dysfunction associated with primary PCI may lead to impaired myocardial reperfusion and worse outcomes. The increased microvascular damage occurs in part due to distal embolization of the thrombus and due to reperfusion injury to the ischemic area.

Coronary thrombus modification might lessen the distal embolization of the thrombus, by less abrupt changes to the thrombus, potentially reducing the damage associated with primary PCI with stent implantation. Ischemic post-conditioning is a coronary thrombus modification that has been introduced to alleviate the injury associated with reperfusion in patients with occluded coronary vessels. Ischemic post-conditioning can be achieved by briefly and repetitively blocking the culprit artery with a balloon inflated at a nominal size before completely reestablishing blood flow to the infarcted artery. The coronary thrombus modification achieved by ischemic post-conditioning could potentially lessen the distal embolization associated with primary PCI also in patient with partially reopened vessels by more slowly modifying the thrombus, and conditioning the damaged microcirculation to better tolerate ischemic damage if distal embolization occurs.

Using the index of microcirculatory resistance (IMR) and the novel microvascular resistance reserve (MRR) microvascular damage and dysfunction can be assessed invasively during primary PCI. Both MRR and IMR can be measured using the thermodilution method, which can be obtained either using continuous (only MRR) or bolus saline injection (MRR and IMR). Continuous thermodilution is obtained using the hyperemic effects of continuous infusion for saline, with minimal influence on hemodynamics, and have previously shown great reproducibility. Meanwhile, bolus thermodilution requires drug-induced hyperemia, usually obtained using intravenous adenosine, without the need for a specialized infusion catheter.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Analysis of CMR data will be performed blided to group assignment and invasive measurement results

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ST-elevation at the J-junction in a minimum of two contiguous ECG leads with a minimum of ≥ 0.1 mV in all leads, except for V2 and V3 (which required ≥ 0.2 for men ≥ 40 years old, ≥ 0.25 in men < 40 years old, or ≥ 0.15 mV for all women) or new left bundle branch
  • Admission to hospital within 12 hours of symptom debut
  • Angiographic signs of a culprit lesion planned to be treated with primary percutaneous coronary intervention

排除标准

  • Age < 18 years or inability to provide informed consent
  • Life expectancy of < 12 months
  • Hemodynamically instability
  • Pregnancy or breastfeeding
  • Known asthma or severe chronic obstructive pulmonary disease
  • Expected inability to perform physiological measurements (due to severely tortuous arteries, ostial disease or very distal disease),
  • CMR contraindications (estimated glomerular filtration rate < 30 mL/min, magnetic or mechanically activated implants, or any prior metal implants, severe claustrophobia)
  • Expected to or unavoidable to use thrombectomy

研究组 & 干预措施

Standard stent implantation

Active Comparator

干预措施: Standard stent implantation (Procedure)

Coronary thrombus modification

Experimental

干预措施: Coronary thrombus modification (Procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验